Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
19.79
+0.04 (0.20%)
At close: Nov 10, 2026, 4:00 PM EST
19.59
-0.20 (-0.99%)
After-hours: Nov 10, 2026, 5:36 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or 24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$6,989
Profits / Employee
-$681,284
Market Cap
1.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 88 | -28 | -24.14% |
| Dec 31, 2024 | 116 | 7 | 6.42% |
| Dec 31, 2023 | 109 | -13 | -10.66% |
| Dec 31, 2022 | 122 | 17 | 16.19% |
| Dec 31, 2021 | 105 | 40 | 61.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| UroGen Pharma | 300 |
| Omeros | 175 |
| Alpha Tau Medical | 121 |
| Vor Biopharma | 76 |
| SpyGlass Pharma | 76 |
| GH Research | 73 |
| Savara | 70 |
SLN News
- 6 days ago - Silence Therapeutics Announces Oral Presentation on SANRECO Phase 2 Study of Divesiran in Polycythemia Vera at ASH 2026 - Business Wire
- 20 days ago - Silence Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 21 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG) - GlobeNewsWire
- 22 days ago - Silence Therapeutics downgraded to Hold from Buy at Jefferies - TheFly
- 22 days ago - Why Merck KGaA Is Paying a 130% Premium for This Gene-Silencing Tech - Barrons
- 22 days ago - Silence Therapeutics downgraded to Market Perform from Outperform at William Blair - TheFly
- 22 days ago - Why Is Silence Therapeutics (SLN) Stock Up 125% Today? - TipRanks
- 22 days ago - Silence Therapeutics downgraded to Neutral from Buy at Chardan - TheFly